FDA wanted large samples and the concern about hypertension addressed. That irritated Leo and he went another direction. Big mistake in my view. Company could have revenue by now...no way IPIX will participate in a P3 ABSSSI trial now...much too late.
Sell off B and liquidate is most likely scenario now.